Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS
* CIPHER PHARMACEUTICALS INC - QTRLY TOTAL REVENUE DECREASED TO $5.6 MILLION FROM $7.0 MILLION.
* CIPHER PHARMACEUTICALS INC - QTRLY NET INCOME FROM CONTINUING OPERATIONS $0.05 PER BASIC AND DILUTED SHARE
* CIPHER PHARMACEUTICALS - INTENDS TO SIGNIFICANTLY INCREASE COLLABORATION WITH TECHNOLOGY PARTNER GALEPHAR PHARMACEUTICAL RESEARCH
* CIPHER PHARMACEUTICALS - COMMERCIAL INVESTMENTS WILL BE ASSUMED BY PARTNERS AND CIPHER INTENDS TO COLLECT UPFRONT PAYMENTS AND ROYALTY STREAMS.